galanthaminone,
Galanthaminone,
Narwedine,
(-)-Narwedine,
(+/-)-Narwedine,
510-77-0,
1668-86-6,
Narwedine, (+/-)-,
Nivaline,
UNII-38CR9WB857,
(-)-Galantamine Hydrobromide,
CHEBI:7487,
Galanthamine, 3-deoxy-3-oxo-,
QENVUHCAYXAROT-YOEHRIQHSA-N,
38CR9WB857,
(4aS,8aS)-3-Methoxy-11-methyl-9,10,11,12-tetrahydro-4aH-benzo[2,3]benzofuro[4,3-cd]azepin-6(5H)-one,
(4aS,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one,
Narwedin,
L-Narwedine,
EC 428-690-2,
SureCN1719363,
3-Deoxy-3-oxo-galanthamine,
SCHEMBL1719363,
CHEMBL2146604,
DTXSID60168190,
HY-I0020,
MFCD08063719,
ZINC15250922,
AKOS025401594,
API0000577,
CS-2734,
AC-22592,
AC-26365,
AJ-67260,
SC-15877,
SC-73414,
C08534,
510G770,
UNII-ATP706417H component QENVUHCAYXAROT-YOEHRIQHSA-N,
(4Ar*,8ar*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro(3a,3,2-ef)(2)benzazepin-6-one,
(4aS,8aS)-3-Methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6H-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-one,
(4aS,8aS)-3-methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6H-benzo[2,3]benzofuro[4,3-cd]azepin-6-one,
5107-70-0,
6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-one, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,8aS)-,
7318-05-0,
Razadyne,
Nivalin,
Reminyl,
(+)-Narwedine,
Galanthamine hydrobromide,
UNII-ATP706417H,
ATP706417H,
(+/-)-3-Deoxy-3-oxogalanthamine,
C17-H19-N-O3,
RW3957,
CID10356588,
(4aR*,8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one,
(4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol Hydrobromide,
[(2R,3R,4S,5R,6R)-6-[2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate,
1953-04-4,
6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-one, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aR,8aR)-rel-,
6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-one,4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,8aS)-,